300109 logo

Boai NKY Medical Holdings Ltd. Stock Price

SZSE:300109 Community·CN¥8.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300109 Share Price Performance

CN¥17.40
0.73 (4.38%)
CN¥17.40
0.73 (4.38%)
Price CN¥17.40

300109 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet average dividend payer.

1 Risk
0 Rewards

Boai NKY Medical Holdings Ltd. Key Details

CN¥1.2b

Revenue

CN¥650.5m

Cost of Revenue

CN¥544.7m

Gross Profit

CN¥370.3m

Other Expenses

CN¥174.4m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.36
45.57%
14.59%
8.9%
View Full Analysis

About 300109

Founded
1987
Employees
1186
CEO
Junzheng Zhang
WebsiteView website
www.boai-nky.com

Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP), Orarez, and in vitro diagnostic products, as well as invests in tumor drugs. It offers its products for pharmaceutical products, such as APIs and excipients; personal care products, including cosmetics, haircare, oral care, and household care; alcohol, soft drinks, and food; battery, petroleum and natural gas, and photovoltaic; and membrane, textile and dyeing, agriculture, stationery, semiconductor, and other industries. The company was formerly known as Boai NKY Pharmaceuticals Ltd. and changed its name to Boai NKY Medical Holdings Ltd. in March 2016. Boai NKY Medical Holdings Ltd. was founded in 1987 and is based in Jiaozuo, China.

Recent 300109 News & Updates

Recent updates

No updates